Member Info for shan

Chris et al
Some really good points
My thoughts are though that we are past the announcement of a recession although the effects of it will be felt later so I don’t expect any massive re rate for nex yet.

Secondly as we have seen with the face mask order I think people will just have to work around Covid until as u all say a vaccine is found

It’s certainly well worth an investment and I have bought in on the basis it is undervalued

Surely as more businesses go back and schools reopen the demand will rise
It has to be worth a long term play

Net assets divided by shares
There are many variations of it so u may have heard right elsewhere too

Will be nice to maybe seen some director buys today
I believe they can now buy as results are out of the way

i know book value isnt the only metric but the book value of NEX is around £2.09...way above the current share price...well worth a look as most have mentioned below...couple that to the massive buys then it all looks good

Lovely jubbly!
Nice and steady rise!

Some research:
Market cap of £450approx and from RNS of 28th July, Q1 figures were down 11% but still £458m. The rns also stated 40% of furloughed workers returned and starting to see customers return. Reduction of overhead costs to save £25M.
Director also buying shares and funding facility extended up to December 2022.
well worth a look

lovely - steady rise!

well worth a look yes
will post some details later after some research

big trades to end!
nice and steady!

well done everyone!

On 31 July 2020 Phillip Bentley purchased 1,074,869 Ordinary Shares of 2.5 pence each in the Company for a total consideration of £348,257.56.

pretty big director buy!

nice rise!

directors buying 3 shares each?!

natural retrace is good and healthy for next rise up

looks good for recovery
recent director buys
rsi low and rising but dyor

seemed to get muted response to any rns here

certainly
and low RSI so well worth a look

USA fda application and approval also?

yes true
although its a good reminder not to get too emotionally attached to a stock